Research ArticleAdult Brain
Open Access
Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study
Y. Forslin, S. Shams, F. Hashim, P. Aspelin, G. Bergendal, J. Martola, S. Fredrikson, M. Kristoffersen-Wiberg and T. Granberg
American Journal of Neuroradiology July 2017, 38 (7) 1311-1316; DOI: https://doi.org/10.3174/ajnr.A5211
Y. Forslin
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
S. Shams
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
F. Hashim
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
P. Aspelin
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
G. Bergendal
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
cNeurology (G.B., S.F.)
J. Martola
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
S. Fredrikson
cNeurology (G.B., S.F.)
dClinical Neuroscience (S.F.), Karolinska Institutet, Stockholm, Sweden.
M. Kristoffersen-Wiberg
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
T. Granberg
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
American Journal of Neuroradiology
Vol. 38, Issue 7
1 Jul 2017
Advertisement
Y. Forslin, S. Shams, F. Hashim, P. Aspelin, G. Bergendal, J. Martola, S. Fredrikson, M. Kristoffersen-Wiberg, T. Granberg
Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study
American Journal of Neuroradiology Jul 2017, 38 (7) 1311-1316; DOI: 10.3174/ajnr.A5211
Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study
Y. Forslin, S. Shams, F. Hashim, P. Aspelin, G. Bergendal, J. Martola, S. Fredrikson, M. Kristoffersen-Wiberg, T. Granberg
American Journal of Neuroradiology Jul 2017, 38 (7) 1311-1316; DOI: 10.3174/ajnr.A5211
Jump to section
Related Articles
Cited By...
- MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis
- Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? An MRS Study in Patients with MS
- Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologists Perspective
- Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS
- Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis
- Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Adult Brain
Patient Safety
Similar Articles
Advertisement